BACKGROUND AND OBJECTIVES: Chronic kidney disease (CKD) is prevalent in minority populations and racial/ethnic differences in survival are incompletely understood. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Secondary analysis of Kidney Early Evaluation Program participants from 2000 through 2008 with CKD, not on dialysis, and without previous kidney transplant was performed. Self-reported race/ethnicity was categorized into five groups: non-Hispanic white, African American, Asian, American Indian/Alaska Native, and Hispanic. CKD was defined as a urinary albumin to creatinine ratio of ≥30 mg/g among participants with an estimated GFR (eGFR) ≥60 ml/min per 1.73 m(2) or an eGFR of <60 ml/min per 1.73 m(2). The outcome was all-cause mortality. Covariates used were age, sex, obesity, diabetes, hypertension, albuminuria, baseline eGFR, heart attack, stroke, smoking, family history, education, health insurance, geographic region, and year screened. RESULTS: 19,205 participants had prevalent CKD; 55% (n = 10,560) were White, 27% (n = 5237) were African American, 9% (n = 1638) were Hispanic, 5% (n = 951) were Asian, and 4% (n = 813) were American Indian/Alaska Native. There were 1043 deaths (5.4%). African Americans had a similar risk of death compared with Whites (adjusted Hazard Ratio (AHR) 1.07, 95% CI 0.90 to 1.27). Hispanics (AHR 0.66, 95% CI 0.50 to 0.94) and Asians (AHR 0.63, 95% CI 0.41 to 0.97) had a lower mortality risk compared with Whites. In contrast, American Indians/Alaska Natives had a higher risk of death compared with Whites (AHR 1.41, 95% CI 1.08 to 1.84). CONCLUSIONS: Significant differences in mortality among some minority groups were found among persons with CKD detected by community-based screening.
BACKGROUND AND OBJECTIVES:Chronic kidney disease (CKD) is prevalent in minority populations and racial/ethnic differences in survival are incompletely understood. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Secondary analysis of Kidney Early Evaluation Program participants from 2000 through 2008 with CKD, not on dialysis, and without previous kidney transplant was performed. Self-reported race/ethnicity was categorized into five groups: non-Hispanic white, African American, Asian, American Indian/Alaska Native, and Hispanic. CKD was defined as a urinary albumin to creatinine ratio of ≥30 mg/g among participants with an estimated GFR (eGFR) ≥60 ml/min per 1.73 m(2) or an eGFR of <60 ml/min per 1.73 m(2). The outcome was all-cause mortality. Covariates used were age, sex, obesity, diabetes, hypertension, albuminuria, baseline eGFR, heart attack, stroke, smoking, family history, education, health insurance, geographic region, and year screened. RESULTS: 19,205 participants had prevalent CKD; 55% (n = 10,560) were White, 27% (n = 5237) were African American, 9% (n = 1638) were Hispanic, 5% (n = 951) were Asian, and 4% (n = 813) were American Indian/Alaska Native. There were 1043 deaths (5.4%). African Americans had a similar risk of death compared with Whites (adjusted Hazard Ratio (AHR) 1.07, 95% CI 0.90 to 1.27). Hispanics (AHR 0.66, 95% CI 0.50 to 0.94) and Asians (AHR 0.63, 95% CI 0.41 to 0.97) had a lower mortality risk compared with Whites. In contrast, American Indians/Alaska Natives had a higher risk of death compared with Whites (AHR 1.41, 95% CI 1.08 to 1.84). CONCLUSIONS: Significant differences in mortality among some minority groups were found among persons with CKD detected by community-based screening.
Authors: Diane L Frankenfield; Sheila H Roman; Michael V Rocco; Marjorie R Bedinger; William M McClellan Journal: Kidney Int Date: 2004-04 Impact factor: 10.612
Authors: Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak Journal: J Am Soc Nephrol Date: 2004-05 Impact factor: 10.121
Authors: Wendy Weinstock Brown; Rosalind M Peters; Suzanne E Ohmit; William F Keane; Allan Collins; Shu-Chen Chen; Karren King; Michael J Klag; Donald A Molony; John M Flack Journal: Am J Kidney Dis Date: 2003-07 Impact factor: 8.860
Authors: Kelly J Hunt; Roy G Resendez; Ken Williams; Steve M Haffner; Michael P Stern; Helen P Hazuda Journal: Am J Epidemiol Date: 2003-12-01 Impact factor: 4.897
Authors: Christine A Stidley; Vallabh O Shah; Marina Scavini; Andrew S Narva; David Kessler; Arlene Bobelu; Jean W MacCluer; Thomas K Welty; Philip G Zager Journal: J Am Soc Nephrol Date: 2003-07 Impact factor: 10.121
Authors: Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; Stacey E Jolly; Joseph V Nally Journal: J Am Soc Nephrol Date: 2015-06-04 Impact factor: 10.121
Authors: Michael J Fischer; Jesse Y Hsu; Claudia M Lora; Ana C Ricardo; Amanda H Anderson; Lydia Bazzano; Magdalena M Cuevas; Chi-Yuan Hsu; John W Kusek; Amada Renteria; Akinlolu O Ojo; Dominic S Raj; Sylvia E Rosas; Qiang Pan; Kristine Yaffe; Alan S Go; James P Lash Journal: J Am Soc Nephrol Date: 2016-05-05 Impact factor: 10.121
Authors: Marino A Bruce; Bettina M Beech; Errol D Crook; Mario Sims; Derek M Griffith; Sean L Simpson; Jamy Ard; Keith C Norris Journal: J Investig Med Date: 2013-04 Impact factor: 2.895
Authors: James P Lash; Ana C Ricardo; Jason Roy; Rajat Deo; Michael Fischer; John Flack; Jiang He; Martin Keane; Claudia Lora; Akinlolu Ojo; Mahboob Rahman; Susan Steigerwalt; Kaixiang Tao; Myles Wolf; Jackson T Wright; Alan S Go Journal: Am J Kidney Dis Date: 2016-05-19 Impact factor: 8.860
Authors: Peter G Linde; Patrick Archdeacon; Matthew D Breyer; Tod Ibrahim; Jula K Inrig; Reshma Kewalramani; Celeste Castillo Lee; Carolyn Y Neuland; Prabir Roy-Chaudhury; James A Sloand; Rachel Meyer; Kimberly A Smith; Jennifer Snook; Melissa West; Ronald J Falk Journal: J Am Soc Nephrol Date: 2016-04-28 Impact factor: 10.121
Authors: Cristina M Arce; Jinnie J Rhee; Katharine L Cheung; Haley Hedlin; Kristopher Kapphahn; Nora Franceschini; Roberto S Kalil; Lisa W Martin; Lihong Qi; Nawar M Shara; Manisha Desai; Marcia L Stefanick; Wolfgang C Winkelmayer Journal: Am J Kidney Dis Date: 2015-09-01 Impact factor: 8.860
Authors: Xuan Hui; Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Tibor Fülöp; Josef Coresh Journal: Am J Kidney Dis Date: 2013-06-13 Impact factor: 8.860